Guided Therapeutics (GTHP) Other Working Capital Changes (2011 - 2026)
Guided Therapeutics' (GTHP) quarterly Other Working Capital Changes came in at -$2000.0 in Q2 2026, down 122.22% year-over-year from $9000.0 in Q2 2025, and up 81.82% quarter-over-quarter from -$11000.0 in Q1 2026.
Powered by 
Analysis
Guided Therapeutics (GTHP) Other Working Capital Changes (2011 - 2026) Analysis & Trends
Guided Therapeutics has disclosed Other Working Capital Changes across 16 years of filings, most recently posting -$2000.0 for Q2 2026.
- In Q2 2026, Other Working Capital Changes fell 122.22% year-over-year to -$2000.0; the TTM figure through Jun 2026 stood at -$503000.0 (down 628.99% YoY), while the FY2025 annual figure was -$660000.0, down 255.29% from the prior year.
- Other Working Capital Changes came in at -$2000.0 for Q2 2026 at Guided Therapeutics, up from -$11000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $695000.0 in Q4 2022 to a low of -$649000.0 in Q3 2022.
- Average Other Working Capital Changes over 5 years is -$8166.7, with a median of -$31500.0 recorded in 2024.
- Year-over-year, Other Working Capital Changes plunged 2050.0% in 2023 and soared 1642.86% in 2024.
- Over 5 years, Other Working Capital Changes stood at -$3000.0 in 2022, then plunged by 766.67% to -$26000.0 in 2023, then surged by 488.46% to $101000.0 in 2024, then tumbled by 595.05% to -$500000.0 in 2025, then surged by 99.6% to -$2000.0 in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were -$2000.0 in Q2 2026, -$11000.0 in Q1 2026, and -$500000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Guided Therapeutics | 24.13 Mn | 24.12 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -58,000.00 |
| Jun 30, 2026 | -58,000.00 |
| Mar 31, 2026 | -21,000.00 |
| Mar 31, 2026 | -21,000.00 |
| Dec 31, 2025 | -33,000.00 |
| Dec 31, 2025 | -33,000.00 |
| Sep 30, 2025 | -25,000.00 |
| Sep 30, 2025 | -25,000.00 |
| Jun 30, 2025 | -39,000.00 |
| Jun 30, 2025 | -39,000.00 |
| Mar 31, 2025 | -111,000.00 |
| Mar 31, 2025 | -111,000.00 |
| Dec 31, 2024 | -38,000.00 |
| Dec 31, 2024 | -38,000.00 |
| Sep 30, 2024 | -30,000.00 |
| Sep 30, 2024 | -30,000.00 |
| Jun 30, 2024 | -44,000.00 |
| Jun 30, 2024 | -44,000.00 |
| Mar 31, 2024 | -8,000.00 |
| Mar 31, 2024 | -8,000.00 |